The Regulatory Affairs and Compliance team at Alnylam Pharmaceuticals is responsible for ensuring that all RNAi therapeutics meet stringent regulatory requirements while maintaining high ethical standards. This team collaborates closely with global regulatory bodies to navigate approval processes, oversees pharmacovigilance and quality assurance, and implements compliance strategies to safeguard patient safety and uphold the company’s commitment to excellence in therapeutics.
Akihiro Sawa
Senior Manager, Regulatory Aff...
Alison Allen
Director, Global Pharmacovigil...
Harshit Udani
Associate Director, Global Pat...
Joel Pagan
Senior Quality Assurance Assoc...
Maged Darwish
Vice President, Global Regulat...
Mariya Sotirova
Director, Global Regulatory Af...
Piyush Sharma
Chief Ethics & Compliance Offi...
View all